Cargando…
Does treating with anti–PD-1 to improve glomerular health come without a cost? Reply.
Autores principales: | Shankland, Stuart J., Pippin, Jeffrey W., Wessely, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663150/ https://www.ncbi.nlm.nih.gov/pubmed/36136431 http://dx.doi.org/10.1172/JCI165287 |
Ejemplares similares
-
Does treating with anti–PD-1 to improve glomerular health come without a cost?
por: Jhaveri, Kenar D., et al.
Publicado: (2022) -
Upregulated PD-1 signaling antagonizes glomerular health in aged kidneys and disease
por: Pippin, Jeffrey W., et al.
Publicado: (2022) -
The glomerular parietal epithelial cell’s responses are influenced by SM22 alpha levels
por: Naito, Shokichi, et al.
Publicado: (2014) -
CD44 impacts glomerular parietal epithelial cell changes in the aged mouse kidney
por: Hamatani, Hiroko, et al.
Publicado: (2020) -
Transcriptional Landscape of Glomerular Parietal Epithelial Cells
por: Gharib, Sina A., et al.
Publicado: (2014)